Welcome to our dedicated page for Ionq SEC filings (Ticker: IONQ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Quantum computing promises transformative returns, yet IonQ’s SEC documents can read like a physics dissertation. Locating R&D burn rates, deciphering option grants, or spotting dilution warnings inside a single IonQ annual report 10-K simplified often takes hours. Stock Titan eliminates that pain. Our AI delivers IonQ SEC filings explained simply, showing the numbers and milestones without the math PhD.
Every time IonQ hits the EDGAR tape, we post the filing within seconds and pair it with machine-written context. Need the next IonQ quarterly earnings report 10-Q filing or an IonQ 8-K material events explained? It’s already summarized. Want alerts the moment a director sells shares? Our feed of IonQ Form 4 insider transactions real-time keeps you ahead. Below you’ll find:
- 10-K & 10-Q breakdowns highlighting cash runway, government contract backlog, and qubit roadmaps.
- Form 4 dashboards for IonQ insider trading Form 4 transactions and IonQ executive stock transactions Form 4.
- Proxy statement insights detailing IonQ proxy statement executive compensation.
- Instant notes on 8-K releases, mergers, or financing updates.
Use these AI summaries to compare quarter-over-quarter progress, monitor insider sentiment, or share concise takeaways with clients. Whether you’re modeling cash needs or validating strategic milestones, understanding IonQ SEC documents with AI turns dense disclosures into actionable clarity. Save time, catch details others miss, and rely on our IonQ earnings report filing analysis to stay informed about the company pushing quantum boundaries.
Insider award disclosure: This Form 4 reports that Inder M. Singh, identified as CFO and COO of IonQ, Inc. (IONQ), was granted 160,294 restricted stock units (RSUs) on 09/04/2025 at no cash price recorded ($0). After the award, the reporting person beneficially owned 165,807 shares of IonQ common stock. The RSUs vest over four years: 25% on September 10, 2026 and then quarterly on December 10, March 10, June 10 and September 10 thereafter, subject to continued service.
The filing was signed by an attorney-in-fact on 09/08/2025. The Form 4 shows a non-derivative acquisition via an equity award and discloses the vesting schedule but does not report any exercised options, cash purchases, or sales.
IonQ CFO Thomas G. Kramer reported the sale of 64,578 shares of IonQ common stock on 09/03/2025 under a pre-established Rule 10b5-1 trading plan adopted March 14, 2025. The shares were sold at a weighted average price of $41.8232, with individual sale prices ranging from $40.59 to $42.98, and the reporting person retains beneficial ownership of 473,302 shares directly plus 5 shares indirectly through a child. The Form 4 was signed by an attorney-in-fact on 09/05/2025.
Form 144 notice reports a proposed sale of 158,330 shares of common stock of the issuer through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $6,806,606.70. The shares were acquired on 02/24/2021 via previously exercised stock options and payment was recorded the same day. The filing lists prior sales by the same account in the past three months totaling 406,630 shares for $16,759,629.40. The notice includes the standard Rule 144 representation and references reliance on 10b5-1 sales in several prior transactions.
IonQ director William J. Teuber Jr. was granted 4,413 restricted stock units (RSUs) on 08/26/2025 as compensation. The RSUs carry a $0 grant price and will vest in full on the earlier of the 2026 Annual Meeting (or immediately prior if his board service ends) or June 18, 2026, provided he continues to serve on the board through the vesting date. The Form 4 reports the transaction as a direct beneficial ownership change and is filed for one reporting person.
IonQ director Jim Frankola received a grant of 4,413 restricted stock units (RSUs) on 08/26/2025. The RSUs were reported on a Form 4 and are scheduled to vest in full on the earlier of the company’s 2026 Annual Meeting (or immediately prior if his board service ends) or June 18, 2026, but only if he remains a board member through the vesting date. The grant was reported as a zero-price award, consistent with typical director compensation in the form of equity awards. The Form 4 was executed by an attorney-in-fact on 08/28/2025.
IonQ, Inc. (IONQ) filed an initial Form 3 reporting that William J. Teuber Jr., listed as a director, does not beneficially own any securities of the issuer as of the event date 08/26/2025. The filing was signed by an attorney-in-fact on 08/28/2025 and includes an Exhibit 24 power of attorney. The document confirms this is an individual filing and no non-derivative or derivative holdings are reported.
IonQ director Jim Frankola submitted an initial Form 3 disclosing his relationship to IonQ, Inc. (IONQ) and stating that he beneficially owns no securities of the company. The event date is
IonQ, Inc. prospectus supplement (Form 424B7) describes registration of shares by selling stockholders and methods for secondary sales, including over-the-counter, privately negotiated or exchange transactions, and refers readers to the Plan of Distribution on page S-13 for details. The document states that directors and officers are not subject to lock-up agreements and therefore, subject to securities laws, may sell shares at any time after September 5, 2025. It incorporates prior SEC filings by reference, including a Form 10-Q for the quarter ended June 30, 2025 filed on August 6, 2025, a 10-K filed February 26, 2025, and an 8-A filed November 10, 2020. The supplement references the company’s QCaaS offering and lists the corporate website https://ionq.com (website content not part of the prospectus).
FAQ
What is the current stock price of Ionq (IONQ)?
What is the market cap of Ionq (IONQ)?
